Evaluating linkage to care for hypertension after community-based screening in rural Uganda by Kotwani, Prashant et al.
Evaluating linkage to care for hypertension after community-
based screening in rural Uganda
Prashant Kotwani1,2, Laura Balzer3, Dalsone Kwarisiima4, Tamara D. Clark1,2, Jane
Kabami2, Dathan Byonanebye2, Bob Bainomujuni2, Douglas Black1,2, Gabriel Chamie1,2,
Vivek Jain1,2, Harsha Thirumurthy5, Moses R. Kamya2,6, Elvin H. Geng1,2, Maya L.
Petersen3, Diane V. Havlir1,2, Edwin D. Charlebois2,7, and The SEARCH Collaboration
1HIV/AIDS Division, San Francisco General Hospital, University of California San Francisco, CA,
USA 2Makerere University-University of California San Francisco Research Collaboration,
Mbarara, Uganda 3School of Public Health, University of California, Berkeley, CA, USA 4Mulago
Joint AIDS Program, Kampala and Mbarara, Uganda 5Gillings School of Global Public Health,
University of North Carolina at Chapel Hill, NC, USA 6Department of Medicine, Makerere
University College of Health Sciences, Kampala, Uganda 7Center for AIDS Prevention Studies,
University of California San Francisco, CA, USA
Abstract
Objectives—To determine the frequency and predictors of hypertension linkage to care after
implementation of a linkage intervention in rural Uganda.
Methods—During a multi-disease screening campaign for HIV, diabetes, and hypertension in
rural Uganda, hypertensive adults received education, appointment to a local health facility and
travel voucher. We measured frequency and predictors of linkage to care, defined as visiting any
health facility for hypertension management within 6 months. Predictors of linkage to care were
calculated using collaborative targeted maximum likelihood estimation (C-TMLE). Participants
not linking were interviewed using a standardized instrument to determine barriers to care.
Results—Over 5 days, 2252 adults were screened for hypertension and 214 hypertensive adults
received a linkage intervention for further management. Of these, 178 (83%) linked to care within
6 months (median = 22 days). Independent predictors of successful linkage included older age,
female gender, higher education, manual employment, tobacco use, alcohol consumption,
hypertension family history, and referral to local versus regional health center. Barriers for
patients who did not see care included expensive transport (59%) and feeling well (59%).
Conclusions—A community health campaign that offered hypertension screening, education,
referral appointment and travel voucher achieved excellent linkage to care (83%). Young adults,
men, and persons with low levels of formal education were among those least likely to seek care.
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INTRODUCTION
Community- and home-based HIV screening programs are cost-effective and successful
methods to reach large numbers of previously untested individuals [1–7]. Given the high
burden of other chronic diseases in sub-Saharan Africa, these innovative screening programs
also are a unique opportunity to diagnose and treat individuals with diseases other than HIV,
such as hypertension. This approach builds efficiency by leveraging resources invested in
HIV testing campaigns as a platform to provide diagnostic services for non-communicable
diseases (NCD) [8].
Hypertension is a high-burden NCD that is particularly well suited to community-based
screening approaches given the ease and speed of sphygmomanometry. However, diagnosis
is only the first step in the “cascade of care” that begins with diagnosis and proceeds to
linkage, initiating therapy, retention, and eventual control of disease (summarized in Figure
1).
Data on retention of hypertensive patients through all steps in the care cascade in resource-
limited settings are lacking. A previous study found low utilization of health care services
after hypertension screening in Tanzania, but did not include a linkage intervention [9]. Only
32% follow-up was reported after hypertension and diabetes screening in Cameroon despite
use of a linkage intervention [10]. Similarly, a recent study in Kenya found poor linkage to
care after community-based screening (31%) but had a very small sample size (35 persons)
[11]. To our knowledge, there has not been a robust assessment of hypertension linkage to
care following community-based screening in sub-Saharan Africa.
The Sustainable East Africa Research in Community Health (SEARCH) collaboration has
pioneered multi-disease screening that integrates HIV and NCD services through
community health campaigns [8]. In a pilot campaign conducted in May 2011 in rural
southwestern Uganda, we found a significant burden of untreated hypertension but
inadequate follow-up after screening [8]. In an effort to understand the second step in the
cascade of hypertension care, in this subsequent study we have tested a linkage strategy
including education, referral appointment to a health facility and transport voucher. Using a
community-based screening campaign, the primary objective of this study was to determine
the frequency and predictors of hypertension linkage to care following implementation of a
linkage intervention in rural Uganda. A secondary objective was to describe barriers to
hypertension care in rural Uganda.
METHODS
Study design and setting
This was a prospective sub-study on hypertension linkage to care nested within a multi-
disease community health campaign (CHC). The study was conducted in May 2012 in
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Kakyerere parish, a community of approximately 6300 persons in Mbarara district in
southwestern Uganda.
Community health campaign
This public health initiative brings rapid diagnostic services for multiple diseases to rural
populations. The CHC is a high-throughput event staffed by local health personnel, offering
services to all community members (approximately 1000 persons/day) at accessible
community sites such as schools or churches. The campaign occurs over 5 days and each
adult participant receives point-of-care screening for HIV, hypertension, and diabetes.
Children are offered HIV testing, rapid diagnosis and treatment for malaria as well as
deworming. The average transit time for the campaign is approximately 90 minutes. Our
group previously described the implementation of a CHC in Mbarara, Uganda in 2011 [8].
Hypertension screening and study population
All community members were invited to participate in the CHC. Each adult responded to an
epidemiologic survey ascertaining basic demographics, occupational and medical history, as
well as substance use. Next, trained staff conducted blood pressure (BP) measurements
using an electronic, automated sphygmomanometer (Honsun LD7A). Subjects were seated
in a chair and rested for approximately one minute before BP was measured. High BP was
defined as systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg. Persons with high BP
underwent two confirmatory measurements one minute apart. The lowest of three
measurements was then used to establish a diagnosis of hypertension in order to minimize
over-diagnosis (false positives) using a single BP measure. In addition, height (to the nearest
0.1 cm) and weight (to the nearest kilogram) were measured in order to calculate body mass
index (BMI) for each participant. Point-of-care random plasma glucose and HIV rapid
testing were also performed.
All adults at the CHC who were hypertensive on screening and self-reported not currently
receiving antihypertensive therapy were invited to participate in the linkage to care sub-
study.
Hypertension linkage intervention
The linkage to care intervention included education, referral appointment to a health facility
and transport voucher. Each participant received an individualized counseling session with
an experienced nurse which included education about the chronic nature of hypertension,
possible complications of untreated disease, need for lifestyle modifications, and potential
necessity for lifelong medications. Each session lasted 5–10 minutes and was performed by
the same nurse for all subjects. Participants were then given a referral appointment to the
nearest local health center (Bwizibwera Health Center IV) or the regional hospital (Mbarara
Regional Referral Hospital) if hypertensive urgency was diagnosed (systolic BP ≥180
mmHg or diastolic BP ≥110 mmHg). Appointments were scheduled 3–30 days after
screening.
The local health center was approximately 5 km away from Kakyerere parish, whereas the
regional hospital was about 30 km away. The cost of a one-way journey to the local heath
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center is approximately 2 United States Dollars (USD), while the cost for a one-way journey
to the regional hospital is approximately 4 USD. Participants were given a travel voucher
that could be reimbursed for a nominal amount upon successful linkage at the local health
center or regional hospital. This amount was similar to the cost of a one-way journey: 5000
Ugandan Shillings (USh) (approximately 2 USD) for the local health center and 10000 USh
(approximately 4 USD) for the regional hospital.
At either health facility, participants were treated per the Ugandan Ministry of Health
guidelines. Government health facilities in Uganda are required to provide free services to
all patients, including antihypertensive medication. Those with refractory hypertension or
complications are usually referred to the regional hospital. However, these health facilities
occasionally run out of medications, which forces patients to purchase medications from
private retail pharmacies. Previously, the monthly cost of purchasing antihypertensive
medicines has been estimated to be 1.1 Euros (1.4 USD) in a similar region [12].
Tracking
Linkage visits were captured using handwritten logbooks at the local health center and the
referral hospital. Travel vouchers with unique study identifiers served to accurately identify
participants who successfully linked to care. Participants who did not visit either health
facility within 6 months were tracked to determine care status and assess barriers to care.
We adapted tracking methods previously implemented in rural Uganda among patients with
HIV [13].
A trained tracker conducted a standardized interview to assess care status and barriers to
care. The tracker was given a list of subjects including their pertinent identifiers (name, sex,
age, and occupation) and residence information (GPS coordinates and village). GPS
coordinates were collected during a community-wide household census prior to the CHC.
For participants who provided a cellphone number, the tracker first attempted to conduct a
phone interview. If unable to conduct a phone interview or no phone number was available,
the tracker visited participants at their home to determine care status. If the tracker failed to
locate the participant on the first visit, at least two more attempts were made. Failing this,
the tracker recorded care status information from close informants (family members,
neighbors, or friends), if known.
Data analysis
Survey data at the CHC were collected via pre-programmed tablets. Tracking interview data
were double entered into Microsoft Access. Stata v.12 (Stata Corporation) and R v.2.15.3 (R
Core Team, 2013) were used for analyses.
Successful linkage to care was defined as visiting any clinic for hypertension care within 6
months. Factors analyzed as predictors of linkage to care were age, gender, level of
education, occupation, smoking status, alcohol consumption, family history of hypertension,
time to appointment, site of appointment (local health center or regional hospital), and
severity of hypertension (Stage 1 or Stage 2). Stage 1 hypertension was defined as systolic
BP 140–159 and/or diastolic BP 90–99 mmHg; and stage 2 hypertension was defined as
systolic BP ≥160 or diastolic BP ≥100 mmHg [14].
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For each predictor variable, collaborative-targeted maximum likelihood (C-TMLE) was
used to estimate the marginal difference in the probability of linking, after adjusting for the
other predictor variables [15]. C-TMLE was implemented instead of parametric logistic
regression for several reasons. First, we wished to obtain point estimates on the additive
scale, instead of estimates on the relative scale, such as odds ratios. Secondly, C-TMLE uses
cross-validation and data-adaptive methods to minimize biased point estimates and inference
that can arise from model misspecification. Briefly, data are split into so-called training and
validation sets. Each a priori-specified algorithm (various parametric regressions or
smoothing algorithms) is fit on the training set and its performance evaluated on the
validation set. This obtains an “honest” measure of estimator performance and avoids over-
fitting. The algorithm with the best performance or the best weighted combination of
inputted algorithms is then used to obtain an initial estimate of the conditional probability of
linking, given all the predictor variables. Next, these initial estimates are updated to further
reduce bias and to obtain valid inference. This targeting step makes use of information in the
so-called propensity score (the conditional probability of each predictor, given the remaining
predictors). Using information in the propensity score can be especially important when the
data are sparse and the outcome is rare. Consequently, C-TMLE is double-robust; it will
yield a consistent estimate if either the conditional probability of linking or the propensity
score is consistently estimated. Finally, C-TMLE averages over the remaining predictor
variables to obtain a marginal estimate of the importance of each predictor on the probability
of linking.
Ethics statement
All subjects provided written consent for participation. The study was reviewed and
approved by the Makerere University School of Medicine Research and Ethics Committee,
the Ugandan National Council on Science and Technology, and the UCSF Committee on
Human Research.
RESULTS
4476 persons from Kakyerere parish attended the CHC; of these 2,282 were adults and
2,252 (99%) (mean/median age 48.5/45 years) were screened for hypertension and answered
an epidemiologic survey at the CHC. 73 adults (3.2%) reported current use of
antihypertensive medications; 281 adults had high BP on screening (12.5%) and did not
report using antihypertensives. Risk factors associated with hypertension included age,
gender, BMI, diabetes, alcohol consumption and family history, which have been discussed
in a separate study [17].
During the CHC, 214 out of 281 participants eligible for the study received the linkage
intervention, forming the study cohort. Due to lapses in staff communication to the
participants, 67 persons left the campaign prior to receiving the linkage intervention.
Demographic characteristics of the study cohort are listed in Table 1. Briefly, participants
were 47.2% women, mean/median age 51.2/49.5 years, 81.3% employed in manual
occupations (mostly farming) and 1.9% HIV positive.
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178 (83%) of the 214 participants who received the linkage intervention (the study cohort)
visited a health facility for hypertension management within 6 months. Data was not
available for the 67 persons who did not receive the linkage intervention; assuming none of
these individuals linked to care, overall 63% (178/281) linkage was achieved.
Median time to linkage was 22 days (interquartile range: 14–24 days; n=163). Of the 36
participants in the study cohort who failed to link to care, 30 did not seek care while 6 were
lost to follow-up (summarized in Figure 2).
Predictors of Linkage to Care
Among the study cohort, after multivariate adjustment, independent predictors of linkage to
care included age, gender, education, occupation, tobacco use, alcohol consumption, family
history, and appointment site. Adjusted risk differences (RD) along with 95% confidence
intervals (CI) are given in Table 2.
Participants ≥60 years were more likely to link than those aged 18–29 years (RD = 36.9%,
95% CI 15.7, 58.2). There was no statistically significant difference in linkage between
those aged 18–29 years, 30–44 years, and 45–59 years. Women had a 14.4% greater
probability of linking than men (RD = 14.4%, 95% CI 5.2, 23.7). Increasing level of
education was associated with an increase in the likelihood of successful linkage. Compared
to those with no formal education, persons with tertiary education or beyond were the most
likely to link to care (RD=19.7%, 95% CI, 8.7, 30.8) followed by those with secondary
education (RD=11.1%, 95% CI 1.6, 20.5).
Manual workers, mostly farmers, were more likely to link than the unemployed (RD=18.5%,
95% CI 4.6, 32.3). Current tobacco use was associated with an increased probability of
linkage to care (RD=11.4%, 95% CI 2.4, 20.4). Subjects with an alcohol consumption of
≥10 drinks per month were also more likely to link than those reporting no alcohol use
(RD=11.4%, 95% CI 2.0, 20.7). Family history of hypertension was a significant predictor
of linkage to care (RD=13.0%, 95% CI 5.7, 20.3). Finally, persons referred to the local
health center were more likely to link than those referred to the regional hospital
(RD=43.4%, 95% CI 35.9, 50.9).
In a separate secondary analysis including the 67 hypertensive persons who did not receive
the linkage intervention, results were similar to the primary analysis. Independent predictors
of linkage to care included age, gender, education, occupation, tobacco use, alcohol
consumption, family history and receiving the linkage intervention (data not shown).
Barriers to Care
After tracking, 30 persons were confirmed to have not linked to care. Of these, 27 persons
were interviewed and barriers to care assessed; 3 persons could not be interviewed and care
status was determined by close informants’ report. Feeling well (59%), expensive
transportation (59%), transportation difficulty/inconvenience (33%), fear of being
reprimanded by the clinic staff for missing a scheduled appointment (26%), family
obligations (22%), and responsibilities at work (22%) were the most common barriers for
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not linking to care (Table 3). Notably, no participant cited stigma as a barrier in open-ended
interview questions.
DISCUSSION
High blood pressure is the leading risk factor for global disease burden and estimated to
cause more than 9 million deaths per year [18]. Hypertension disproportionately affects the
developing world – 80% of cardiovascular deaths occur in low- and middle-income
countries [19,20]. Africa, in particular, has been noted to have the highest prevalence of
hypertension among adults older than 25 years [21]. Early treatment of hypertension can
reduce future complications such as heart disease, stroke, kidney disease, and retinopathy.
However, a weak care cascade with inadequate screening, failure to link to care, and
inability to adequately treat chronic disease leads to high morbidity, mortality, and lost
economic output associated with NCDs like hypertension in developing nations [22].
We screened 2252 adults during a 5-day multi-disease screening campaign in rural Uganda
and found that 63% of adults with untreated hypertension successfully linked to care within
6 months. Among the study cohort who received a linkage intervention, 83% linkage was
achieved. This study provides the first sound estimate of the efficacy of a linkage to care
intervention following community-based hypertension screening in sub-Saharan Africa. Our
multi-disease screening approach also shows that efforts to scale up HIV testing and linkage
at the community level can be successfully leveraged to identify and link persons with
NCDs such as hypertension.
Within the context of a chronic care cascade for hypertension, this study illuminates the
critical first steps of diagnosis and linkage-to-care. Our study identifies sub-populations
most likely to be lost at the step following diagnosis. These data can inform targeted
interventions to prevent loss of patients after community-based screening. Younger (18–29
years) persons were less likely to link to care than those ≥60 years. Although youth were
less likely to engage in care, they represent a small percentage of the overall burden of
hypertension in this community. On the other hand, men represent a large proportion of the
hypertension burden, but were less likely to link to care than women. Interventions focusing
on men are needed to enhance linkage from community-based screening campaigns.
Persons with little or no formal education had lower probability of linking to care than those
with secondary or tertiary education. This finding emphasizes the need for increasing
awareness and health literacy surrounding hypertension, perhaps through public health
initiatives like the CHC. Higher linkage observed at the local health center compared to the
regional hospital may be explained by their distance from Kakyerere parish. The local health
center is significantly closer to the community (~5 km) than the regional hospital (~30 Km).
Distance being an important consideration in a low-income setting where transport can be
relatively expensive is understandable.
Interestingly, current tobacco users and persons consuming higher amounts of alcohol (≥10
drinks/month) were more likely to link to care. These persons are perhaps already at an
increased risk for complications related to hypertension, such as heart disease and stroke. It
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is likely that a community-based approach could be successful in reaching out to these high-
risk groups. Family history also increased likelihood of linkage to care. Receiving
encouragement or perhaps sharing the cost of a journey with a family member may
contribute to this finding. Finally, manual laborers (mostly farmers), a large majority of this
community, were more likely to link than the unemployed.
Tracking subjects who did not link allowed us to identify important barriers to care faced by
rural Ugandans in our pilot study. Transportation expenses and inconvenience were
prominent issues, which is consistent with expectations from a rural area with poor roads
and accessibility [23]. Possible outreach could include decentralized care strategies such as
home-based screening and treatment for patients living in especially remote areas. Likewise,
feeling healthy or lack of symptoms was another common reason for failure to link. This has
been reported previously in the HIV linkage to care literature as well [24,25]. Improving
patient education surrounding asymptomatic hypertension seems essential to effectively link
patients to care. Fear of being reprimanded by clinic staff was also a barrier to care and has
been described as a barrier to retention in care for other diseases [26]. Sensitization efforts to
promote therapeutic alliances and decrease “bad patient” labeling by health care workers are
needed in this region.
We included travel vouchers in the linkage intervention, which likely boosted linkage
frequency, but to an unknown extent. The amount of this voucher approximated the cost of a
one-way journey to the health facilities and participants were still required to invest
significant time and resources in order to link to care. Yet, this small voucher may have
reinforced participants’ intrinsic motivations to seek care and substantially affected linkage
frequency. It is possible that in the absence of travel vouchers linkage frequency may be
reduced. Similar studies assessing linkage interventions without a travel voucher would help
determine what fraction of linkage to care is attributable to transport reimbursement.
Although this study was population-based, limitations include loss of eligible subjects due to
unintended operational deficiencies. Specifically, a temporal delay between receiving a
diagnosis of hypertension and obtaining the linkage intervention may have confused some
participants and led them to leave the CHC prematurely. Those who did not receive an
appointment were more likely to be younger, though there were no significant differences by
gender (data not shown). It is possible that the few subjects who did not receive the linkage
intervention were also those at higher risk of failing to link. Moreover, since participation in
the CHC was voluntary, it is possible that individuals with greater health-seeking tendencies
came to the campaign, thereby contributing to the high frequency of linkage to care. Our
pilot study included a relatively small number of hypertensive adults (n=214) and results
should be interpreted cautiously. With only 36 subjects not linking to care and poor
representation of certain predictor variables, estimation with standard logistic regression
could result in over-fitting and biased point estimates. To minimize these risks and obtain
reliable inference, we used C-TMLE with various penalized regression procedures and
provide the first report on predictors of hypertension linkage to care in this region. Finally,
given the need for streamlined hypertension screening during the CHC, BP measurement in
our study was not in accordance with standard guidelines; however, by using the lowest of
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three measurements we attempted to minimize misclassification bias resulting from using
just a single BP measurement.
Despite these limitations, this study provides much needed insights into linkage to care. So
far, limited studies have evaluated the care cascade for NCDs in sub-Saharan Africa. Nurse-
led hypertension clinics in Cameroon retained only 14% of patients at one year with most
dropouts occurring after the initial linkage visit [27]. In a similar setting, Labhardt et al.
reported extremely low retention (18%) of hypertension and diabetes patients [28]. Though
these few reports on retention in care have shown poor results, they also represent a key
opportunity to further evaluate and improve all steps in the chronic care cascade. In fact, in a
subsequent trial, Labhardt et al. reported a significant increase in retention rates at one year
through low-cost interventions like treatment contracts and reminder letters for missed
appointments [12].
In conclusion, a linkage strategy following community-based hypertension screening
achieved excellent linkage to care (83%); identified young adults, men, and persons with
low levels of formal education as least likely to link; and revealed transport costs and
asymptomatic disease state as barriers to linkage in rural Uganda. However, further work is
needed to elucidate the various aspects of the chronic care cascade for hypertension in this
region. In the context of an ongoing community-based study in East Africa (NCT01864603)
we are in the process of describing retention and re-engagement through all steps in the
hypertension care cascade.
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Figure 1. Hypertension care cascade
A concept map outlining each step involved in the successful treatment of hypertension.
This process begins with community or clinic-based hypertension screening initiatives. Once
hypertension is diagnosed, the next key steps - linkage, retention, and re-engagement -
ensure continued engagement in care. These steps are crucial to retain patients in care and
achieve successful blood pressure control.
HTN = hypertension.
Adapted from: Mugavero MJ, Norton WE, Saag MS. Health care system and policy factors
influencing engagement in HIV medical care: piecing together the fragments of a fractured
health care delivery system. Clin Infect Dis. 2011;52:S238–S246.
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Figure 2. Study schema for the hypertension linkage to care intervention
281 adults from Kakyerere parish were eligible to participate in the study; however, 214
adults received the hypertension linkage to care intervention and formed the study cohort.
178 (83%) of these linked to care within 6 months. 30 subjects were determined to have not
linked to care while 6 were lost to follow-up. Persons who did not link were tracked and
interviewed to determine barriers to care.
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Table 1









18–29 23 (10.8%) 15 (8.4%) 8 (22.2%)
30–44 63 (29.4%) 55 (30.9%) 8 (22.2%)
45–59 53 (24.8%) 46 (25.8%) 7 (19.4%)
≥60 75 (35.0%) 62 (34.8%) 13 (36.1%)
Gender
Women 101 (47.2%) 86 (48.3%) 15 (41.7%)
Men 113 (52.8%) 92 (51.7%) 21 (58.3%)
BMIa
≤25 146 (68.5%) 119 (67.2%) 27 (75.0%)
25–30 40 (18.8%) 33 (18.6%) 7 (19.4%)
≥30 27 (12.7%) 25 (14.1%) 2 (5.6%)
Blood pressure (BP, in mm Hg)
Systolic BP Mean (SD) 154.5 (15.6) 154.9 (15.1) 152.8 (18.1)
Diastolic BP Mean (SD) 89.6 (12.5) 89.6 (12.3) 89.5 (14.0)
Severity of hypertension
Stage 1 (140–159/90–99 mmHg) 140 (65.4%) 118 (66.3%) 22 (61.1%)
Stage 2 (≥160/≥110 mmHg) 74 (34.6%) 60 (33.7%) 14 (38.9%)
Occupation
Unemployed 25 (11.7%) 16 (9.0%) 9 (25.0%)
Manual 174 (81.3%) 150 (84.3%) 24 (66.7%)
Sedentary 15 (7.0%) 12 (6.7%) 3 (8.3%)
Education level
None 69 (32.2%) 55 (30.9%) 14 (38.9%)
Primary 95 (44.4%) 79 (44.4%) 16 (44.4%)
Secondary 38 (17.8%) 33 (18.5%) 5 (13.9%)
Tertiary and beyond 12 (5.6%) 11 (6.2%) 1 (2.8%)
Current tobacco user
No 176 (82.2%) 143 (80.3%) 33 (91.7%)
Yes 38 (17.8%) 35 (19.7%) 3 (8.3%)
Alcohol useb (drinks per month)
None 111 (52.1%) 91 (51.4%) 20 (55.6%)
0–10 49 (23.0%) 37 (20.9%) 12 (33.3%)
≥10 53 (24.9%) 49 (27.7%) 4 (11.1%)
HIV
No 210 (98.1%) 175 (93.8%) 35 (97.2%)
Yes 4 (1.9%) 3 (1.7%) 1 (2.8%)































0–7 176 (82.2%) 145 (81.5%) 31 (86.1%)
7–11 34 (15.9%) 30 (16.8%) 4 (11.1%)
≥11.1 4 (1.9%) 3 (1.7%) 1 (2.8%)
Family historyc
No 160 (76.9%) 132 (75.9%) 28 (82.4%)
Yes 48 (23.1%) 42 (24.1%) 6 (17.6%)
Time to appointment
0–2 weeks 60 (28.0%) 49 (27.5%) 11 (30.6%)
2–3 weeks 22 (10.3%) 18 (10.1%) 4 (11.1%)
3–4 weeks 132 (61.7%) 111 (62.4%) 21 (58.3%)
Appointment site
Regional hospital 22 (10.3%) 17 (9.6%) 5 (13.9%)
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Table 2
Estimated risk differences from C-TMLE analysis. The asterisk indicates significance at the α=0.05 level (N =
207a).
Proportion that linked to care (%) Adjusted Risk Difference, RD (%) 95% CI p-value
Age (years)
18–29 15/23 = 65.2% Ref Ref Ref
30–44 55/63 = 87.3% 19.0 (−3.4, 41.4) 0.096
45–59 46/53 = 86.8% 14.9 (−8.0, 37.8) 0.202
≥60 62/75 = 82.7% 36.9 (15.7, 58.2) 0.001*
Gender
Men 92/113 = 81.4% Ref Ref Ref
Women 86/101 = 85.2% 14.4 (5.2, 23.7) 0.002*
Education
None 55/69 = 79.7% Ref Ref Ref
Primary 79/95 = 83.2% 5.5 (−5.7, 16.7) 0.335
Secondary 33/38 = 86.8% 11.1 (1.6, 20.5) 0.021*
Tertiary and beyond 11/12 = 91.7% 19.7 (8.7, 30.8) <0.001*
Occupation
Unemployed 16/25 = 64.0% Ref Ref Ref
Manual 150/174 = 86.2% 18.5 (4.6, 32.3) 0.009*
Sedentary 12/15 = 80.0% 1.7 (−14.6, 18.0) 0.840
Current tobacco use
No 143/176 = 81.2% Ref Ref Ref
Yes 35/38 = 92.1% 11.4 (2.4, 20.4) 0.013*
Alcohol (drinks/month)
None 91/111=82.0% Ref Ref Ref
0–10 37/49 = 75.5% −7.0 (−20.2, 6.2) 0.299
>10 49/53 = 92.4% 11.4 (2.0, 20.7) 0.017*
Family history
No 132/160 = 82.5% Ref Ref Ref
Yes 42/48 = 87.5% 13.0 (5.7, 20.3) 0.001*
Time to appointment
0–2 weeks 49/60 = 81.7% Ref Ref Ref
2–3 weeks 18/22 = 81.8% 8.2 (−4.4, 20.7) 0.203
3–4 weeks 111/132 = 84.1% −0.2 (−11.0, 10.6) 0.965
Appointment site
Regional hospital 17/22 = 77.3% Ref Ref Ref
Local health center 161/192 = 83.8% 43.4 (35.9, 50.9) <0.001*
Severity of hypertension
Stage 1 118/140 = 84.3% Ref Ref Ref
Stage 2 60/74 = 81.1% 2.7 (−6.2, 11.6) 0.556
a
Seven observations were removed due to missing data.
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Table 3
Barriers to care identified during patient tracking (N=27).
Barrier Number of responses
N (%)
Medical 19 (70%)
I felt well and thought I didn’t need care 16 (59%)
I felt too sick to come to clinic 2 (7%)
I have taken medicine for hypertension before and it did not help me feel better 2 (7%)
In the past, I have experienced side effects from antihypertensive medications 1 (4%)
I didn’t want to take drugs forever 1 (4%)
I was afraid of side-effects from starting new medicines 0
I was taking too many pills a day 0
I was drinking alcohol 0
Access to Care 17 (63%)
Transportation was too expensive 16 (59%)
Transportation was too difficult or inconvenient 9 (33%)
Work and Family 9 (33%)
Work interfered with visiting clinic for review 6 (22%)
I had family obligations 6 (22%)
Clinic Factor 8 (30%)
I was afraid clinic staff would scold me for missing appointment 7 (26%)
The staff is not nice 1 (4%)
Inconvenient clinic hours 1 (4%)
The clinics frequently run out of medications (“stock- out”) 0
The care is not good 0
It takes a long time to be seen at the clinic 0
The waiting area is not comfortable 0
Alternative Treatment and Advice 0
A family member or other important person told me to not go to clinic 0
Because I went to someone who tried/is trying to cure me by prayer/religious rituals 0
Because I saw/am seeing a traditional healer instead 0
Because I saw/am seeing a herbalist/nutritionist instead 0
Other 6 (22%)
I forgot my appointment 4 (15%)
Other 2 (7%)
Declines to answer 0
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